Literature DB >> 1704258

Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.

A E Mast1, J J Enghild, S V Pizzo, G Salvesen.   

Abstract

Proteinase inhibitors of the serpin superfamily may exist in one of three distinct conformations: the native form, a fully active protein with the reactive site loop intact; the proteolytically modified form in which inhibitory capacity is abolished; and the proteinase-complexed form, a stable equimolar complex between the inhibitor and a target proteinase. Here, the specificity and kinetics of the plasma elimination of different serpin conformations are compared. Proteinase-complexed serpins were rapidly cleared from the circulation. However, the native and modified forms were not cleared rapidly, indicating that the receptor-mediated pathways which recognize the complexes fail to recognize the native and modified forms. This result suggests that significant structural differences exist between modified and proteinase-complexed serpins. The structural differences were probed by using transverse urea gradient gel electrophoresis, a technique that allows comparisons of the conformational stabilities of proteins. With the exception of the noninhibitory serpins ovalbumin and angiotensinogen, the modified and proteinase-complexed serpins were both stabilized thermodynamically compared to the native forms. In addition, the proteinase component of the serpin-proteinase complex was usually thermodynamically stabilized. These data are used to compare the conformations of serpin-proteinase complexes with those of native and modified serpins; they are discussed in terms of a model whereby serpins inhibit proteinases in a manner similar to that described for other types of protein inhibitors of serine proteinases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704258     DOI: 10.1021/bi00220a039

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  The active site is the least stable structure in the unfolding pathway of a multidomain cold-adapted alpha-amylase.

Authors:  Khawar S Siddiqui; Georges Feller; Salvino D'Amico; Charles Gerday; Laura Giaquinto; Ricardo Cavicchioli
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

2.  Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.

Authors:  Jan K Jensen; Klavs Dolmer; Peter G W Gettins
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

Review 3.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

Review 4.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

Review 5.  Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema.

Authors:  R Mahadeva; D A Lomas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  Serpin-Enzyme Receptors LDL Receptor-Related Protein 1.

Authors:  Dudley K Strickland; Selen Catania Muratoglu; Toni M Antalis
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Analysis of surface cavity in serpin family reveals potential binding sites for chemical chaperone to reduce polymerization.

Authors:  Poonam Singh; Mohammad Sazzad Khan; Asma Naseem; Mohamad Aman Jairajpuri
Journal:  J Mol Model       Date:  2011-06-17       Impact factor: 1.810

Review 8.  Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen.

Authors:  Pierre Corvol; Noel Lamandé; Amauri Cruz; Jerome Celerier; Jean-Marie Gasc
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  An examination of the inhibitory mechanism of serpins by analysing the interaction of trypsin and chymotrypsin with alpha 2-antiplasmin.

Authors:  J J Enghild; Z Valnickova; I B Thøgersen; S V Pizzo; G Salvesen
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

10.  Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design.

Authors:  Bibek Gooptu; Elena Miranda; Irene Nobeli; Meera Mallya; Andrew Purkiss; Sarah C Leigh Brown; Charlotte Summers; Russell L Phillips; David A Lomas; Tracey E Barrett
Journal:  J Mol Biol       Date:  2009-02-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.